COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication

The aim of this multi-centre survey is to assess treatment adherence and quality of life in a Jordanian and Lebanese population newly diagnosed with hypertension or with uncontrolled essential hypertension being on antihypertensive treatment for at least 6 months.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

High Blood Pressure Cardiovascular Diseases Hypertension Vascular Diseases

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients older than 21 years of age
Patients newly diagnosis with essential hypertension or with hypertension that is uncontrolled after being under the same antihypertensive treatment for at least 6 months (based on the criteria established by the Joint National Committee VII)
Patients capable of providing an informed consent

Exclusion criteria

Patients with secondary hypertension
Pregnant women or nursing mothers
Patients with acute illnesses or psychiatric diagnosis

Treatment and study plan

Primary outcomes

Compliance rate

Time frame: 6 months

Identify the percentage of subjects compliant to their antihypertensive treatment.

Secondary outcomes

Health Related Quality of Life (MINICHAL Score)

Time frame: 6 months

To compare and identify changes in the quality of life before and after anti-hypertensive treatment.
Type of pharmacological treatments

Time frame: 6 months

To identify the pharmacological treatments used by physicians in Jordan and Lebanon to treat patients newly diagnosed or with uncontrolled hypertension.
Factors affecting adherence to treatment

Time frame: 6 months

To identify associated factors that may alter adherence to anti-hypertensive treatment.
Compliance rate by antihypertensive regimen used

Time frame: 6 months

To compare treatment rate for different antihypertensive regimen used
Percentage of controlled patients

Time frame: 6 months

To identify the percentage of patients reaching their target blood pressure according to the JNCVII criteria.

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2012
First posted: Jan 11, 2011
Registry last updated: Sep 11, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed